US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist
  • 0.2396
  • -0.0084-3.39%
Close Oct 18 16:00 ET
  • 0.2318
  • -0.0078-3.26%
Post 20:01 ET
3.20MMarket Cap-237P/E (TTM)

InMed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
Total revenue
11.18%4.6M
-44.48%1.28M
13.41%1.17M
163.99%1.24M
181.14%901.86K
279.61%4.14M
348.96%2.31M
233.97%1.03M
77.22%469.78K
320.79K
Operating revenue
11.18%4.6M
-44.48%1.28M
13.41%1.17M
163.99%1.24M
181.14%901.86K
279.61%4.14M
348.96%2.31M
233.97%1.03M
77.22%469.78K
--320.79K
Cost of revenue
27.97%3.5M
10.30%817K
4.96%883.14K
170.53%916.06K
8.48%880.62K
400.56%2.73M
179.46%740.69K
560.93%841.41K
120.55%338.62K
811.81K
Gross profit
-21.53%1.1M
-70.32%466.07K
50.36%289.46K
147.13%324.14K
104.33%21.24K
158.13%1.4M
528.87%1.57M
5.61%192.51K
17.58%131.16K
-491.02K
Operating expense
-5.59%9.24M
18.62%2.48M
-10.94%2.09M
-14.22%2.03M
-11.46%2.65M
-31.76%9.78M
-36.71%2.09M
-37.08%2.34M
-46.53%2.37M
3.30%2.99M
Selling and administrative expenses
-10.21%5.25M
-13.87%1.21M
-2.73%1.37M
-6.89%1.36M
-16.77%1.3M
-14.85%5.85M
-19.11%1.41M
-26.23%1.41M
-20.25%1.46M
13.67%1.56M
-General and administrative expense
-10.21%5.25M
-13.87%1.21M
-2.73%1.37M
-6.89%1.36M
-16.77%1.3M
-14.85%5.85M
-19.11%1.41M
-26.23%1.41M
-20.25%1.46M
13.67%1.56M
Research and development costs
0.88%3.77M
93.41%1.21M
-25.22%656.76K
-28.37%609.79K
-6.28%1.29M
-48.75%3.73M
-58.44%623.74K
-49.91%878.3K
-66.44%851.36K
-7.55%1.38M
Depreciation amortization depletion
8.58%219.6K
2.44%54.77K
8.05%54.77K
12.61%55.23K
11.79%54.83K
8.94%202.25K
-0.97%53.46K
-4.97%50.69K
-1.50%49.05K
71.91%49.05K
-Depreciation and amortization
8.58%219.6K
2.44%54.77K
8.05%54.77K
12.61%55.23K
11.79%54.83K
8.94%202.25K
-0.97%53.46K
-4.97%50.69K
-1.50%49.05K
71.91%49.05K
Operating profit
2.92%-8.13M
-289.14%-2.01M
16.43%-1.8M
23.69%-1.7M
24.57%-2.62M
39.25%-8.38M
83.06%-516.26K
39.28%-2.15M
48.19%-2.23M
-20.28%-3.48M
Net non-operating interest income expense
7.20%527.9K
-30.24%103.64K
-21.89%121.46K
44.01%166.76K
87.42%136.04K
412.48%492.44K
340.81%148.56K
402.19%155.5K
340.68%115.8K
1,310.00%72.59K
Non-operating interest income
7.20%527.9K
-30.24%103.64K
-21.89%121.46K
44.01%166.76K
87.42%136.04K
412.48%492.44K
340.81%148.56K
402.19%155.5K
340.68%115.8K
1,310.00%72.59K
Other net income (expense)
-28.53%-61.92K
-181.01%-25.2K
-1,662.02%-48.16K
195.97%59.9K
49.94%-48.46K
99.02%-48.18K
100.64%31.11K
-108.28%-2.73K
573.00%20.24K
-15.07%-96.79K
Gain on sale of security
-28.53%-61.92K
-181.01%-25.2K
-1,662.02%-48.16K
195.97%59.9K
49.94%-48.46K
96.64%-48.18K
102.25%31.11K
-108.28%-2.73K
573.00%20.24K
-15.07%-96.79K
Income before tax
3.35%-7.67M
-473.57%-1.93M
13.70%-1.72M
29.55%-1.48M
27.59%-2.54M
57.34%-7.93M
95.72%-336.59K
42.56%-2M
51.01%-2.1M
-17.90%-3.5M
Income tax
-45.80%7.1K
294.44%7.1K
0
0
0
13.1K
1.8K
1.5K
3K
6.8K
Net income
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
50.94%-2.1M
-18.12%-3.51M
Net income continuous Operations
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
50.94%-2.1M
-18.12%-3.51M
Minority interest income
Net income attributable to the parent company
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
50.94%-2.1M
-18.12%-3.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
50.94%-2.1M
-18.12%-3.51M
Basic earnings per share
68.92%-1.01
-167.86%-0.19
70.00%-0.18
79.12%-0.19
81.28%-0.76
90.20%-3.25
102.15%0.28
90.23%-0.6
88.23%-0.91
34.20%-4.06
Diluted earnings per share
68.92%-1.01
-167.86%-0.19
70.00%-0.18
79.12%-0.19
81.28%-0.76
90.20%-3.25
102.15%0.28
90.23%-0.6
88.23%-0.91
34.20%-4.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022
Total revenue 11.18%4.6M-44.48%1.28M13.41%1.17M163.99%1.24M181.14%901.86K279.61%4.14M348.96%2.31M233.97%1.03M77.22%469.78K320.79K
Operating revenue 11.18%4.6M-44.48%1.28M13.41%1.17M163.99%1.24M181.14%901.86K279.61%4.14M348.96%2.31M233.97%1.03M77.22%469.78K--320.79K
Cost of revenue 27.97%3.5M10.30%817K4.96%883.14K170.53%916.06K8.48%880.62K400.56%2.73M179.46%740.69K560.93%841.41K120.55%338.62K811.81K
Gross profit -21.53%1.1M-70.32%466.07K50.36%289.46K147.13%324.14K104.33%21.24K158.13%1.4M528.87%1.57M5.61%192.51K17.58%131.16K-491.02K
Operating expense -5.59%9.24M18.62%2.48M-10.94%2.09M-14.22%2.03M-11.46%2.65M-31.76%9.78M-36.71%2.09M-37.08%2.34M-46.53%2.37M3.30%2.99M
Selling and administrative expenses -10.21%5.25M-13.87%1.21M-2.73%1.37M-6.89%1.36M-16.77%1.3M-14.85%5.85M-19.11%1.41M-26.23%1.41M-20.25%1.46M13.67%1.56M
-General and administrative expense -10.21%5.25M-13.87%1.21M-2.73%1.37M-6.89%1.36M-16.77%1.3M-14.85%5.85M-19.11%1.41M-26.23%1.41M-20.25%1.46M13.67%1.56M
Research and development costs 0.88%3.77M93.41%1.21M-25.22%656.76K-28.37%609.79K-6.28%1.29M-48.75%3.73M-58.44%623.74K-49.91%878.3K-66.44%851.36K-7.55%1.38M
Depreciation amortization depletion 8.58%219.6K2.44%54.77K8.05%54.77K12.61%55.23K11.79%54.83K8.94%202.25K-0.97%53.46K-4.97%50.69K-1.50%49.05K71.91%49.05K
-Depreciation and amortization 8.58%219.6K2.44%54.77K8.05%54.77K12.61%55.23K11.79%54.83K8.94%202.25K-0.97%53.46K-4.97%50.69K-1.50%49.05K71.91%49.05K
Operating profit 2.92%-8.13M-289.14%-2.01M16.43%-1.8M23.69%-1.7M24.57%-2.62M39.25%-8.38M83.06%-516.26K39.28%-2.15M48.19%-2.23M-20.28%-3.48M
Net non-operating interest income expense 7.20%527.9K-30.24%103.64K-21.89%121.46K44.01%166.76K87.42%136.04K412.48%492.44K340.81%148.56K402.19%155.5K340.68%115.8K1,310.00%72.59K
Non-operating interest income 7.20%527.9K-30.24%103.64K-21.89%121.46K44.01%166.76K87.42%136.04K412.48%492.44K340.81%148.56K402.19%155.5K340.68%115.8K1,310.00%72.59K
Other net income (expense) -28.53%-61.92K-181.01%-25.2K-1,662.02%-48.16K195.97%59.9K49.94%-48.46K99.02%-48.18K100.64%31.11K-108.28%-2.73K573.00%20.24K-15.07%-96.79K
Gain on sale of security -28.53%-61.92K-181.01%-25.2K-1,662.02%-48.16K195.97%59.9K49.94%-48.46K96.64%-48.18K102.25%31.11K-108.28%-2.73K573.00%20.24K-15.07%-96.79K
Income before tax 3.35%-7.67M-473.57%-1.93M13.70%-1.72M29.55%-1.48M27.59%-2.54M57.34%-7.93M95.72%-336.59K42.56%-2M51.01%-2.1M-17.90%-3.5M
Income tax -45.80%7.1K294.44%7.1K00013.1K1.8K1.5K3K6.8K
Net income 3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M50.94%-2.1M-18.12%-3.51M
Net income continuous Operations 3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M50.94%-2.1M-18.12%-3.51M
Minority interest income
Net income attributable to the parent company 3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M50.94%-2.1M-18.12%-3.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M50.94%-2.1M-18.12%-3.51M
Basic earnings per share 68.92%-1.01-167.86%-0.1970.00%-0.1879.12%-0.1981.28%-0.7690.20%-3.25102.15%0.2890.23%-0.688.23%-0.9134.20%-4.06
Diluted earnings per share 68.92%-1.01-167.86%-0.1970.00%-0.1879.12%-0.1981.28%-0.7690.20%-3.25102.15%0.2890.23%-0.688.23%-0.9134.20%-4.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data